Cargando…

Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus

Detalles Bibliográficos
Autores principales:	Albugami, Muneerah M., Ahmed, Mohammed, Alobaid, Dhari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485657/ https://www.ncbi.nlm.nih.gov/pubmed/32952519 http://dx.doi.org/10.4103/sjmms.sjmms_325_20

Ejemplares similares

Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus
por: Chauhan, Sukhjinder, et al.
Publicado: (2023)

Empagliflozin induced euglycemic diabetic ketoacidosis. A case reports
por: Altowayan, Waleed M.
Publicado: (2022)

Empagliflozin: Euglycemic and hyperglycaemic diabetic ketoacidosis: case report
Publicado: (2021)

SUN-LB030 Empagliflozin Causing Euglycemic Diabetic Ketoacidosis
por: Thomas, Mathew, et al.
Publicado: (2019)

A Rare Case of Empagliflozin-Induced Euglycemic Diabetic Ketoacidosis Obscured by Alkalosis
por: Fernandez Felix, Daniel A, et al.
Publicado: (2022)

Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin
por: Sexe, Jordan, et al.
Publicado: (2020)

The DKA that wasn't: a case of euglycemic diabetic ketoacidosis due to empagliflozin
por: Candelario, Nellowe, et al.
Publicado: (2016)

ODP192 Empagliflozin associated Euglycemic Diabetic Ketoacidosis and the Terrible Triad
por: Nievera, Karl Homer, et al.
Publicado: (2022)

Postop Complication With Euglycemic Diabetic Ketoacidosis in a Patient Receiving Empagliflozin
por: Fustiga, João, et al.
Publicado: (2022)

SAT439 Euglycemic Diabetic Ketoacidosis When Combining Empagliflozin With Cocaine
por: Squicimari-de Cardenas, Fabio Alejandro, et al.
Publicado: (2023)

Immediate Euglycemic Diabetic Ketoacidosis After Gastric Bypass in a Patient with Type II Diabetes
por: Lo, Yu-Ting, et al.
Publicado: (2021)

Euglycemic diabetic ketoacidosis and COVID‐19: A combination to foresee in pregnancy
por: Velasco, Inés, et al.
Publicado: (2021)

SAT-LB118 Euglycemic Diabetic Ketoacidosis in Type 2 Diabetes Mellitus
por: Arao, Kevin A, et al.
Publicado: (2020)

Sodium-glucose co-transporter 2 inhibitors induced euglycemic diabetic ketoacidosis within four days of initiation
por: Razok, Almurtada, et al.
Publicado: (2022)

Post-surgical Euglycemic Diabetic Ketoacidosis in a Patient on Empagliflozin in the Intensive Care Unit
por: Bteich, Fernand, et al.
Publicado: (2019)

Euglycemic Diabetic Ketoacidosis after a Single Dose of Empagliflozin in a Patient with Pancreatitis
por: Calçada, Marta Brandão, et al.
Publicado: (2021)

Euglycemic diabetic ketoacidosis caused by empagliflozin complicated by failure to thrive in a geriatric patient
por: Rathore, Azeem, et al.
Publicado: (2023)

Misleading Presentation of Euglycemic Diabetic Ketoacidosis: Implication for Low-Mid-Income Communities
por: Nwose, Ezekiel Uba, et al.
Publicado: (2015)

Diabetic Ketoacidosis in an Euglycemic Patient
por: Mumtaz, Hassan, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis in Pregnancy
por: de Alencar, Júlio César Garcia, et al.
Publicado: (2019)

Detection of Euglycemic Diabetic Ketoacidosis During Thoracic Surgery 75 Hours After Empagliflozin Discontinuation
por: Nishida, Ai, et al.
Publicado: (2022)

Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review
por: Sampani, Erasmia, et al.
Publicado: (2020)

Euglycemic diabetic ketoacidosis after the initiation of dulaglutide in patient with type 2 diabetes
por: Alduraibi, Rabia Khalid, et al.
Publicado: (2023)

Euglycemic Diabetic Ketoacidosis, a Misleading Presentation of Diabetic Ketoacidosis
por: Thawabi, Mohammad, et al.
Publicado: (2015)

Acute Pancreatitis-Induced Euglycemic Diabetic Ketoacidosis
por: Chaudhry, Arslan, et al.
Publicado: (2021)

Euglycemic diabetic ketoacidosis: A rare but serious side effect of sodium-glucose co-transporter 2 inhibitors
por: Lakušić, Nenad, et al.
Publicado: (2022)

Euglycemic diabetic ketoacidosis associated with uremia
por: Zhang, Mingxia, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis With SGLT-2 Inhibitor
por: Manas, F N U, et al.
Publicado: (2021)

A Case of Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus and COVID-19
por: Morrison, Nathan, et al.
Publicado: (2020)

Dapagliflozin-induced Late-onset Euglycemic Diabetic Ketoacidosis
por: Iqbal, Iqra, et al.
Publicado: (2019)

Early detection of euglycemic ketoacidosis during thoracic surgery associated with empagliflozin in a patient with type 2 diabetes: A case report
por: Kitahara, Chie, et al.
Publicado: (2020)

Diabetic Euglycemic Ketoacidosis Induced by Oral Antidiabetics Type SGLT2i
por: Velasco de Cos, Guillermo, et al.
Publicado: (2021)

Dapagliflozin-associated euglycemic diabetic ketoacidosis in a patient with type 2 diabetes mellitus: A case report
por: Lee, In Hee, et al.
Publicado: (2020)

Euglycemic Diabetic Ketoacidosis in a Patient With Gestational Diabetes Mellitus and COVID-19 Infection
por: Karuppasamy, Gowri, et al.
Publicado: (2021)

Euglycemic Diabetic Ketoacidosis in a Patient with Cocaine Intoxication
por: Abu-Abed Abdin, Asma, et al.
Publicado: (2016)

Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors
por: Chow, Erica, et al.
Publicado: (2023)

Newer Perspectives of Mechanisms for Euglycemic Diabetic Ketoacidosis
por: Yu, Xiaofang, et al.
Publicado: (2018)

An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists
por: Kang, Cyra-Yoonsun, et al.
Publicado: (2022)

Euglycemic diabetic ketoacidosis: A missed diagnosis
por: Nasa, Prashant, et al.
Publicado: (2021)

A Case of SGLT2 Inhibitor-Induced Euglycemic Diabetic Ketoacidosis
por: Rao, Shiavax J, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3fh2vbcuodcne3slkusd1l38nc